Anti SARS-CoV-2 S424-433 T Cells

Donor #: 401
Size: 1-2M cells/vial
Price: $ 650.00
In Stock: 44
Need More?
Request additional quantity

Donor Details

Blood Type : ANeg
Age : 31
Gender : Female
Ethnicity : Caucasian
Anticoagulant : Unknown
HLA-A : 02:01,02:01
HLA-B : 18:01,40:01
HLA-C : 03:04,07:01
HLA-DRβ 1 : 08:01,12:01
CMV : Positive

Additional Donor Information:

An HLA-A*0201-restricted T cell line with the specificity for the KLPDDFTGCV, a peptide that corresponds to the Spike protein (position 424-433) of the novel coronavirus SARS-CoV-2.

Healthy CMV seropositive female non-smoker. She takes Flonase for seasonal allergies. Genotype at FcgRIIIa is F/F

Need something more unique?
Submit a custom request.

About COVID-19 Vaccinated PBMCs

Our COVID-19 vaccinated PBMCs are derived from consented healthy donors without previous COVID-19 infection who received a COVID-19 vaccine from Moderna, Pfizer, or Johnson & Johnson.

COVID-19 vaccinated PBMCs (time series) are collected at the following times:

  • Before COVID-19 vaccination
  • 10-30 days after the first vaccination
  • 10-30 days after the second vaccination, when applicable

About COVID-19 Vaccinated Plasma

Our COVID-19 vaccinated plasma is separated from peripheral blood by centrifugation from consented healthy donors without previous COVID-19 infection who received a COVID-19 vaccine from Moderna, Pfizer, or Johnson & Johnson.

COVID-19 vaccinated plasma (time series) is collected at the following times:

  • Before COVID-19 vaccination
  • 10-30 days after the first vaccination
  • 10-30 days after the second vaccination, when applicable

About COVID-19 Vaccinated Serum

Our COVID-19 vaccinated serum is collected in vacuum tubes without additives from consented healthy donors with no previous COVID-19 infection who received a COVID-19 vaccine from Moderna, Pfizer, or Johnson & Johnson.

COVID-19 vaccinated serum (time series) is collected at the following times:

  • Before COVID-19 vaccination
  • 10-30 days after the first vaccination
  • 10-30 days after the second vaccination, when applicable